What are OCUL's recent SEC filings?
Ocular Therapeutix elected Riad Sherif, M.D. to its Board of Directors effective November 6, 2026, and announced that Seung Suh Hong, Ph.D. resigned from the Board effective December 31, 2026. Dr. Hong's resignation was not due to any disagreement with the Board or management.
View full filing details →Ocular Therapeutix, Inc. furnished a Form 8-K announcing its financial results for the quarter ended September 30, 2026, with the full press release attached as Exhibit 99.1.
View full filing details →Ocular Therapeutix filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.
View full filing details →Ocular Therapeutix filed a routine Form 8-K cover page with no substantive event disclosed in the provided text.
View full filing details →Has OCUL ever done a stock split?
No stock splits are recorded for OCUL.
What is OCUL's share float?
Get Real-Time OCUL Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free